| Glypican 3 expression in human nonneoplastic, preneoplastic, and neoplastic tissues: a tissue microarray analysis of 4,387 tissue samples D Baumhoer, L Tornillo, S Stadlmann, M Roncalli, EK Diamantis, ... American journal of clinical pathology 129 (6), 899-906, 2008 | 302 | 2008 |
| Ki-67 immunoreactivity in human central nervous system tumors: a study with MIB 1 monoclonal antibody on archival material E Karamitopoulou, E Perentes, I Diamantis, T Maraziotis Acta neuropathologica 87, 47-54, 1994 | 242 | 1994 |
| Tumour budding: a promising parameter in colorectal cancer A Lugli, E Karamitopoulou, I Zlobec British journal of cancer 106 (11), 1713-1717, 2012 | 232 | 2012 |
| Tumour microenvironment of pancreatic cancer: immune landscape is dictated by molecular and histopathological features E Karamitopoulou British journal of cancer 121 (1), 5-14, 2019 | 207 | 2019 |
| Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas E Karamitopoulou, E Perentes, M Tolnay, A Probst Human pathology 29 (2), 140-145, 1998 | 165 | 1998 |
| Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer E Karamitopoulou, I Zlobec, V Kölzer, A Kondi-Pafiti, ES Patsouris, ... Modern pathology 26 (2), 295-301, 2013 | 163 | 2013 |
| Integrated genomic and immunophenotypic classification of pancreatic cancer reveals three distinct subtypes with prognostic/predictive significance M Wartenberg, S Cibin, I Zlobec, E Vassella, S Eppenberger-Castori, ... Clinical cancer research 24 (18), 4444-4454, 2018 | 160 | 2018 |
| Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer M Horcic, VH Koelzer, E Karamitopoulou, L Terracciano, G Puppa, ... Human pathology 44 (5), 697-705, 2013 | 159 | 2013 |
| Tumour budding is a strong and independent prognostic factor in pancreatic cancer E Karamitopoulou, I Zlobec, D Born, A Kondi-Pafiti, P Lykoudis, A Mellou, ... European journal of cancer 49 (5), 1032-1039, 2013 | 149 | 2013 |
| CD8+ lymphocytes/tumour-budding index: an independent prognostic factor representing a ‘pro-/anti-tumour’approach to tumour host interaction in colorectal cancer A Lugli, E Karamitopoulou, I Panayiotides, P Karakitsos, G Rallis, G Peros, ... British journal of cancer 101 (8), 1382-1392, 2009 | 147 | 2009 |
| A multiscale map of the stem cell state in pancreatic adenocarcinoma NK Lytle, LP Ferguson, N Rajbhandari, K Gilroy, RG Fox, A Deshpande, ... Cell 177 (3), 572-586. e22, 2019 | 130 | 2019 |
| Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome VH Koelzer, K Canonica, H Dawson, L Sokol, ... Oncoimmunology 5 (4), e1106677, 2016 | 128 | 2016 |
| Intratumoral budding as a potential parameter of tumor progression in mismatch repair–proficient and mismatch repair–deficient colorectal cancer patients A Lugli, T Vlajnic, O Giger, E Karamitopoulou, ES Patsouris, G Peros, ... Human pathology 42 (12), 1833-1840, 2011 | 125 | 2011 |
| Neonatal Fc receptor expression in dendritic cells mediates protective immunity against colorectal cancer K Baker, T Rath, MB Flak, JC Arthur, Z Chen, JN Glickman, I Zlobec, ... Immunity 39 (6), 1095-1107, 2013 | 118 | 2013 |
| HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic marker G Sconocchia, S Eppenberger-Castori, I Zlobec, E Karamitopoulou, ... Neoplasia 16 (1), 31-W15, 2014 | 114 | 2014 |
| Tumor infiltration by FcγRIII (CD16)+ myeloid cells is associated with improved survival in patients with colorectal carcinoma G Sconocchia, I Zlobec, A Lugli, D Calabrese, G Iezzi, E Karamitopoulou, ... International journal of cancer 128 (11), 2663-2672, 2011 | 111 | 2011 |
| p53 protein immunoreactivity in extrahepatic bile duct and gallbladder cancer: correlation with tumor grade and survival I Diamantis, E Karamitopoulou, E Perentes, A Zimmermann Hepatology 22 (3), 774-779, 1995 | 102 | 1995 |
| Loss of the CBX7 protein expression correlates with a more aggressive phenotype in pancreatic cancer E Karamitopoulou, P Pallante, I Zlobec, L Tornillo, V Carafa, T Schaffner, ... European journal of cancer 46 (8), 1438-1444, 2010 | 101 | 2010 |
| HMGA1 and HMGA2 protein expression correlates with advanced tumour grade and lymph node metastasis in pancreatic adenocarcinoma S Piscuoglio, I Zlobec, P Pallante, R Sepe, F Esposito, A Zimmermann, ... Histopathology 60 (3), 397-404, 2012 | 96 | 2012 |
| Glucagon-like-peptide-1 receptor expression in normal and diseased human thyroid and pancreas B Waser, A Blank, E Karamitopoulou, A Perren, JC Reubi Modern Pathology 28 (3), 391-402, 2015 | 90 | 2015 |
